Tagged reovirus

Press Release

New Study Spotlights Potential of Virus To Treat Certain Lung Cancer Patients

 A new study reports that reovirus has the potential to treat certain lung cancer patients, when the reovirus is combined with two other substances known as paclitaxel and carboplatin. Read More
Press Release

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Part of U.S. Phase 2 Pancreatic Cancer Clinical Trial

 The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC. Read More
Press Release

Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study

 The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. Read More
Press Release

Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the International Symposium

 The researchers concluded that reovirus can be successfully delivered specifically to colorectal liver metastases following intravenous administration as a monotherapy and that pre-operative treatment was safe. Read More
Press Release

Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® in Head and Neck Cancers

 Oncolytics Biotech Inc announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin. Read More
Press Release

Reovirus Therapy May Optimize the Efficacy of Irinotecan in Colorectal Cancer

 There may be new hope for colorectal cancer patients who fail on first-line drug combinations harnessed against tumors that harbor a mutation in the kras oncogene. Read More
Press Release

Study Gives Better Understanding Of How Reoviruses And Chemo Work Together

 Researchers at Weill Cornell Medical Center in New York have demonstrated that a reovirus therapy called REOLYSIN works synergistically with gemcitabine and may be worth further investigation. Read More